共 50 条
- [31] TAS4464, A Highly Potent and Selective Inhibitor of NEDD8-Activating Enzyme, Suppresses Neddylation and Shows Antitumor Activity in Diverse Cancer ModelsMOLECULAR CANCER THERAPEUTICS, 2019, 18 (07) : 1205 - 1216Yoshimura, ChihokoMuraoka, HiromiOchiiwa, HiroakiTsuji, ShingoHashimoto, AkihiroKazuno, HiromiNakagawa, FumioKomiya, YuSuzuki, SatoshiTakenaka, ToruKumazaki, MasafumiFujita, NaoyaMizutani, TakashiOhkubo, Shuichi
- [32] The Potent, Highly Selective and Orally Bioavailable Spleen Tyrosine Kinase Inhibitor GSK143 Demonstrates Efficacy in B Cell Receptor and Fc Receptor Signalling in Models of Inflammatory and Autoimmune DiseaseARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S877 - S877Dickson, Marion C.Smithers, NicholasLewis, HuwRamirez-Molina, CesarMcCleary, ScottBarker, MikeLiddle, John
- [33] E7090, a Novel Selective Inhibitor of Fibroblast Growth Factor Receptors, Displays Potent Antitumor Activity and Prolongs Survival in Preclinical ModelsMOLECULAR CANCER THERAPEUTICS, 2016, 15 (11) : 2630 - 2639Miyano, Saori WatanabeYamamoto, YujiKodama, KotaroMiyajima, YukikoMikamoto, MasakiNakagawa, TakayukiKuramochi, HirokoFunasaka, SetsuoNagao, SatoshiSugi, Naoko HataOkamoto, KiyoshiMinoshima, YukinoriNakatani, YusukeKaroji, YukiOhashi, IsaoYamane, YoshinobuOkada, ToshimiMatsushima, TomohiroMatsui, JunjiIwata, MasaoUenaka, ToshimitsuTsuruoka, Akihiko
- [34] TY-1091, a highly selective and potent second-generation RET inhibitor, demonstrates superior antitumor activity in multiple RET-mutant modelsCANCER RESEARCH, 2023, 83 (07)Niu, ChengshanZheng, MaolinWang, HuanJi, KaigeLi, MeihuaWang, GuohuiNi, RongzhenLiang, ApengGong, AishenZhang, YazhenSu, HuiJiang, MingyuChen, ShaoqingChen, XiuguiLi, JunWu, Yusheng
- [35] Damage Incorporated: Discovery of the Potent, Highly Selective, Orally Available ATR Inhibitor BAY 1895344 with Favorable Pharmacokinetic Properties and Promising Efficacy in Monotherapy and in Combination Treatments in Preclinical Tumor ModelsJOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (13) : 7293 - 7325Luecking, UlrichWortmann, LarsWengner, Antje M.Lefranc, JulienLienau, PhilipBriem, HansSiemeister, GerhardBoemer, UlfDenner, KarstenSchaefer, MartinaKoppitz, MarcusEis, KnutBartels, FlorianBader, BenjaminBone, WilhelmMoosmayer, DieterHolton, Simon J.Eberspaecher, UweGrudzinska-Goebel, JoannaSchatz, ChristophDeeg, GesaMumberg, Dominikvon Nussbaum, Franz
- [36] K0706, A Potent Orally Bioavailable Brain-Penetrating Selective Inhibitor of cABL Protein Tyrosine Kinase, Exhibits Neuroprotective Activity in Preclinical Models of Parkinson's DiseaseMOVEMENT DISORDERS, 2019, 34Mandhane, S.Soni, D.Jani, K.Sengupta, P.Patel, A.Bambal, R.Ramanathan, V.Zala, Y.Dharmadhikari, N.Rao, C.Raghavan, A.Damle, N.
- [37] TAS4464, a novel highly potent NEDD8 activating enzyme inhibitor, demonstrates antitumor activity in multiple myeloma through the inactivation of NF-κB pathwaysCANCER RESEARCH, 2015, 75Muraoka, HiromiYoshimura, ChihokoTsuji, ShingoSuzuki, TakamasaHashimoto, AkihiroMizutani, TakashiOhkubo, ShuichiMatsuo, KenichiLwasawa, YoshikazuUtsugi, Teruhiro
- [38] Discovery of a novel and highly selective CDK9 kinase inhibitor (JSH-009) with potent antitumor efficacy in preclinical acute myeloid leukemia modelsInvestigational New Drugs, 2020, 38 : 1272 - 1281Li WangChen HuAoli WangCheng ChenJiaxin WuZongru JiangFengming ZouKailin YuHong WuJuan LiuWenliang WangZuowei WangBeilei WangZiping QiQingwang LiuWenchao WangLili LiJian GeJing LiuQingsong Liu
- [39] PIN-A1, a novel Casein Kinase 1α-selective molecular glue degrader, demonstrates strong antitumor activity via activation of the p53 pathway in preclinical models of AML with a favorable safety profileEUROPEAN JOURNAL OF CANCER, 2022, 174 : S20 - S20Jung, J.Park, J.Mohanty, S.Kim, Y.Levy, D.King-Underwood, J.Deninno, M.Baek, J.Choi, W.Lee, S.Lee, D.Kang, H.Brotz, T.Terrett, N.Jo, H.Kim, Y.
- [40] OXA-01, novel potent mTORC1/TORC2 kinase inhibitor, demonstrates broad spectrum antitumor activity in preclinical models of human cancerEJC SUPPLEMENTS, 2008, 6 (12): : 82 - 82Gokhale, P. C.Bhagwat, S. V.Crew, A. P.Cooke, A.Mantis, C.Workman, J. E.Landfair, D.Bittner, M.Pachter, J. A.Wild, R.